- Home
- PVLA vs HOV Comparison
PVLA vs HOV Comparison
Compare PVLA & HOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PVLA
- HOV
- Stock Information
- Founded
- PVLA 2015
- HOV 1959
- Country
- PVLA United States
- HOV United States
- Employees
- PVLA N/A
- HOV N/A
- Industry
- PVLA Biotechnology: Pharmaceutical Preparations
- HOV Homebuilding
- Sector
- PVLA Health Care
- HOV Consumer Discretionary
- Exchange
- PVLA Nasdaq
- HOV Nasdaq
- Market Cap
- PVLA 888.0M
- HOV 877.2M
- IPO Year
- PVLA N/A
- HOV N/A
- Fundamental
- Price
- PVLA $81.40
- HOV $113.30
- Analyst Decision
- PVLA Strong Buy
- HOV Hold
- Analyst Count
- PVLA 13
- HOV 1
- Target Price
- PVLA $99.38
- HOV $120.00
- AVG Volume (30 Days)
- PVLA 163.2K
- HOV 102.7K
- Earning Date
- PVLA 11-11-2025
- HOV 12-04-2025
- Dividend Yield
- PVLA N/A
- HOV N/A
- EPS Growth
- PVLA N/A
- HOV N/A
- EPS
- PVLA N/A
- HOV 20.64
- Revenue
- PVLA N/A
- HOV $3,140,315,000.00
- Revenue This Year
- PVLA N/A
- HOV N/A
- Revenue Next Year
- PVLA N/A
- HOV $6.78
- P/E Ratio
- PVLA N/A
- HOV $5.62
- Revenue Growth
- PVLA N/A
- HOV 7.83
- 52 Week Low
- PVLA $11.17
- HOV $81.15
- 52 Week High
- PVLA $85.30
- HOV $202.00
- Technical
- Relative Strength Index (RSI)
- PVLA 59.88
- HOV 32.32
- Support Level
- PVLA $78.99
- HOV $119.19
- Resistance Level
- PVLA $85.03
- HOV $127.80
- Average True Range (ATR)
- PVLA 5.58
- HOV 5.53
- MACD
- PVLA -0.02
- HOV -0.63
- Stochastic Oscillator
- PVLA 63.39
- HOV 0.20
About PVLA Palvella Therapeutics Inc. Common Stock
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.
About HOV Hovnanian Enterprises Inc.
Hovnanian Enterprises Inc conducts all of its homebuilding and financial services operations . The company designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes in planned residential developments. It has two distinct operations: homebuilding and financial services. Its homebuilding operations are divided geographically into three segments; Northeast which includes Delaware, Maryland, New Jersey, Ohio, Pennsylvania, Virginia and West Virginia; Southeast which includes Florida, Georgia and South Carolina; and West which includes Arizona, California and Texas. The firm generates maximum revenue from West Segment.